Home » News » Awards & Advancement » SAFE-BioPharma named Computerworld Laureate

SAFE-BioPharma named Computerworld Laureate

Monday, March 26, 2012

SAFE-BioPharma, the global digital identity and digital signature standard for the life sciences and healthcare sectors, has been named a 2012 Computerworld Laureate.

IDG’s Computerworld Honors Program, which recognizes visionary applications of information technology promoting positive social, economic and educational change, has recognized the SAFE-BioPharma standard for its role in facilitating cloud-based collaboration between National Cancer Institute researchers and their private sector counterparts to accelerate initiation of a cancer clinical trial while lowering its costs and reducing paper-reliance. 

The public and private cancer researchers were provisioned with interoperable digital identities, a form of software installed on a computer, cell phone or other device, which establishes a close link with the user’s proven identity and allows for the application of digital signatures to electronic documents. Unlike simple electronic signatures, digital signatures cryptographically guarantee the integrity of documents to which they are affixed. In the pilot study, the electronic documents were placed in the cloud, where the researchers were able to access, sign, and exchange them immediately. Prior to the study, the signature process was delayed by travel and the use of courier, fax, etc.

The 2012 Computerworld Laureates will be recognized publicly at the laureate medal ceremony and gala evening on June 4 in Washington, D.C.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!